A-Alpha Bio Announces Industry-First Data Consortium to Solve AI Protein Engineering's Experimental Data Bottleneck. Founding members include GSK, Boltz, Cradle, and Dyno Therapeutics.

Consortium members will steer the experimental design with A-Alpha Bio to generate the large-scale, standardized antibody-antigen affinity and structural datasets needed to advance AI antibody engineering. Consortium members will steer the experimental design…

Seattle, WA, July 22, 2026 (GLOBE NEWSWIRE) -- A-Alpha Bio, a synthetic biology and machine learning biotechnology company that measures and engineers protein-protein interactions, today announced th… [+5902 chars]

Originally published by GlobeNewswire

Related stories